TrialClinical endocrinology2025

A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in China.

Xiaoping Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.